Search Results

This prestigious recognition program acknowledges and honors individuals who were chosen by their peers and the senior editors of Modern Healthcare as the most influential figures in the industry in terms of leadership and impact.

An internationally renowned research scientist at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine – Phoenix has been awarded a multimillion-dollar grant from the National Institutes of Health (NIH) to develop new treatment methods for lung disease in premature infants.

As an accomplished surgeon, leader and professor, Dr. Fraser will be tasked with ensuring pediatric patients receive high-quality, family-centered surgical care whether they’re receiving treatment at Phoenix Children’s Hospital — Thomas Campus, a new site of service in the west or east Valley or one of the health system’s outpatient surgery centers.

Pediatric patients who have severe forms of lung disease associated with respiratory failure often need transplantable lung tissues and this study proves generating transplantable lungs from stem cells using large animals as bioreactors is possible.

In a move that strengthens the medical leadership of Phoenix Children’s, the health system today announced a new chief medical officer (CMO) as well as the expansion of the CMO office to include two associate CMOs.

In his new role, Dr. Patel leads four of Phoenix Children’s eight clinical centers. He also oversees hospitalist medicine, mental and behavioral health, and Phoenix Children’s Pediatrics practices. Beyond his clinical responsibilities, Dr. Patel is now part of the health system’s Executive Physician Leadership team and the Phoenix Children’s Medical Group Governance Council.